Clinical study on the safety and effectiveness of CART cells in the treatment of advanced refractory GUCY2C-positive advanced colorectal cancer
Ontology highlight
ABSTRACT: Interventions: Experimental group:CART cells
Primary outcome(s): Safety and objective remission rate of CAR-T targeted therapy in patients with advanced urinary tract tumors (complete remission [CR] + partial remission [PR]
Study Design: Single arm
DISEASE(S): Late Colorectal Cancer
PROVIDER: 36236 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA